APOL3 and chronic kidney disease: We suggest that the protective effects of wild-type APOL3 on CKD, most markedly observed in monoallelic APOL1 G1/G2 carriers, contribute to the general lack of kidney injury induced by 1 copy of the APOL1 risk alleles, but not by 2 copies of the APOL1 risk alleles.